Acamprosate reduces motor cortex excitability determined by transcranial magnetic stimulation

Citation
K. Wohlfarth et al., Acamprosate reduces motor cortex excitability determined by transcranial magnetic stimulation, NEUROPSYCHB, 42(4), 2000, pp. 183-186
Citations number
28
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROPSYCHOBIOLOGY
ISSN journal
0302282X → ACNP
Volume
42
Issue
4
Year of publication
2000
Pages
183 - 186
Database
ISI
SICI code
0302-282X(2000)42:4<183:ARMCED>2.0.ZU;2-6
Abstract
Acamprosate is effective in reducing alcohol intake in weaned alcoholics, W e were interested if acamprosate had an effect on the excitability of corti cal motoneurons determined by transcranial magnetic stimulation (TMS), We s tudied 12 male healthy volunteers (mean age 29.5 years, SD = 4.8) who were either treated with 6 tablets of acamprosate (each containing 333 mg verum) per day or placebo (randomized cross-over design) for 1 week. TMS was perf ormed after each treatment session including a paired stimulation paradigm. Motor evoked potentials (MEPs) of the placebo and verum group did not diff er with respect to paired stimulation, However, motor threshold increased i n the acamprosate group (verum: 61.5% (SD = 7.9) vs. placebo: 58.9% (SD = 8 .8), p = 0.036), We conclude that acamprosate leads to a hypoexcitability o f the motor cortex. This might be due to subcortical mechanisms, e.g. thala mocortical pathways since intracortical inhibition and facilitation was not affected. Copyright (C) 2000 S. Karger AG, Basel.